1019 related articles for article (PubMed ID: 32793593)
1. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
[TBL] [Abstract][Full Text] [Related]
2. Development of an m6A-Related lncRNAs Signature Predicts Tumor Stemness and Prognosis for Low-Grade Glioma Patients.
Xu D; Li P; Zhang C; Shen Y; Cai J; Wei Q; Cao M; Xu Z; Wu D; Wang H; Bi X; Wang B; Li K
Stem Cells Int; 2024; 2024():2062283. PubMed ID: 38229597
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma.
Feng R; Li H; Meng T; Fei M; Yang C
Discov Oncol; 2024 May; 15(1):187. PubMed ID: 38797784
[TBL] [Abstract][Full Text] [Related]
4. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database.
Zhu XL; Li Q; Shen J; Shan L; Zuo ED; Cheng X
Transl Cancer Res; 2021 Dec; 10(12):5337-5351. PubMed ID: 35116381
[TBL] [Abstract][Full Text] [Related]
5. Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma.
Huang F; Wang X; Zhong J; Chen H; Song D; Xu T; Tian K; Sun P; Sun N; Qin J; Song Y; Ma W; Liu Y; Yu D; Meng X; Jiang C; Xuan H; Qian D; Cai J
Cancer Cell Int; 2023 Aug; 23(1):156. PubMed ID: 37542290
[TBL] [Abstract][Full Text] [Related]
6. MrGPS: an m6A-related gene pair signature to predict the prognosis and immunological impact of glioma patients.
Zhang N; Yang F; Zhao P; Jin N; Wu H; Liu T; Geng Q; Yang X; Cheng L
Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38171932
[TBL] [Abstract][Full Text] [Related]
7. AL360181.1 promotes proliferation and invasion in colon cancer and is one of ten m6A-related lncRNAs that predict overall survival.
Luo Y; Xie Y; Wu D; Wang B; Lu H; Wang Z; Quan Y; Han B
PeerJ; 2023; 11():e16123. PubMed ID: 37953780
[TBL] [Abstract][Full Text] [Related]
8. Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma.
Wu F; Zhao Z; Chai R; Liu Y; Wang K; Wang Z; Li G; Huang R; Jiang H; Zhang K
Cancer Cell Int; 2018; 18():107. PubMed ID: 30069164
[TBL] [Abstract][Full Text] [Related]
9. An alternative extension of telomeres related prognostic model to predict survival in lower grade glioma.
Cai Y; Guo H; Zhou J; Zhu G; Qu H; Liu L; Shi T; Ge S; Qu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13575-13589. PubMed ID: 37515613
[TBL] [Abstract][Full Text] [Related]
10. Glycolysis‑related lncRNA may be associated with prognosis and immune activity in grade II‑III glioma.
Yang T; Zhang R; Cui Z; Zheng B; Zhu X; Yang X; Huang Q
Oncol Lett; 2024 May; 27(5):238. PubMed ID: 38601183
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel signature based on M6a modification regulators related LncRNA for stratification of the prognosis of prostate cancer.
Wang SX; Xie XH
Environ Toxicol; 2024 Apr; 39(4):2340-2349. PubMed ID: 38156438
[TBL] [Abstract][Full Text] [Related]
12. Developing a lncRNA Signature to Predict the Radiotherapy Response of Lower-Grade Gliomas Using Co-expression and ceRNA Network Analysis.
Li Z; Cai S; Li H; Gu J; Tian Y; Cao J; Yu D; Tang Z
Front Oncol; 2021; 11():622880. PubMed ID: 33767991
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9796081. PubMed ID: 38189018
[TBL] [Abstract][Full Text] [Related]
14. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma.
Hong W; Liang L; Gu Y; Qi Z; Qiu H; Yang X; Zeng W; Ma L; Xie J
Mol Ther Nucleic Acids; 2020 Dec; 22():937-947. PubMed ID: 33251044
[TBL] [Abstract][Full Text] [Related]
15. Joint analysis of lncRNA m
Lv Z; Sun L; Xu Q; Xing C; Yuan Y
Cancer Cell Int; 2020; 20():464. PubMed ID: 32982586
[TBL] [Abstract][Full Text] [Related]
16. An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.
Sun Z; Jing C; Xiao C; Li T
Aging (Albany NY); 2020 Aug; 12(15):15624-15637. PubMed ID: 32805727
[TBL] [Abstract][Full Text] [Related]
17. Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas.
Xu S; Tang L; Dai G; Luo C; Liu Z
Front Cell Dev Biol; 2020; 8():594112. PubMed ID: 33240891
[TBL] [Abstract][Full Text] [Related]
18. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
Front Oncol; 2020; 10():1119. PubMed ID: 32974125
[No Abstract] [Full Text] [Related]
19. Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma.
Li Y; Gu J; Xu F; Zhu Q; Chen Y; Ge D; Lu C
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33003204
[TBL] [Abstract][Full Text] [Related]
20. Prognosis Analysis and Validation of m
Lin S; Xu H; Zhang A; Ni Y; Xu Y; Meng T; Wang M; Lou M
Front Oncol; 2020; 10():541401. PubMed ID: 33123464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
